Found: 6
Select item for more details and to access through your institution.
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis.
- Published in:
- FASEB Journal, 2024, v. 38, n. 13, p. 1, doi. 10.1096/fj.202302659R
- By:
- Publication type:
- Article
Towards large‐scale steady‐state enhanced nuclear magnetization with in situ detection.
- Published in:
- Magnetic Resonance in Chemistry, 2021, v. 59, n. 12, p. 1208, doi. 10.1002/mrc.5161
- By:
- Publication type:
- Article
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 6, p. 456, doi. 10.1002/mus.27819
- By:
- Publication type:
- Article
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 5, p. 378, doi. 10.1002/mus.27807
- By:
- Publication type:
- Article
Safety and activity of anti‐CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
- Published in:
- Muscle & Nerve, 2023, v. 67, n. 5, p. 354, doi. 10.1002/mus.27775
- By:
- Publication type:
- Article
An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitor.
- Published in:
- 2022
- By:
- Publication type:
- journal article